Headquarters
RIIA TN 130B/2, TARTU, TARTU 50411, EE
TARTU, TARTU, EE
From the company
Chemestmed is an Estonian biotech company developing first-in-class drugs to treat CNS and metabolic diseases and disorders. It works in epitranscriptomics, developing a technological platform for discovery of novel drugs based on mRNA regulation in cells, including small-molecule activators targeting the METTL3/METTL14 methyltransferase complex to enhance RNA m⁶A methylation.
RIIA TN 130B/2, TARTU, TARTU 50411, EE
Quantities, certifications, and timing.